PA SB1126

Health insurers in Pennsylvania must cover at least two prescribed epinephrine delivery systems (auto-injectors or nasal spray devices) per year at a maximum out-of-pocket cost of $35, regardless of deductibles or other cost-sharing requirements

The requirement applies to individual and group health insurance policies, including high deductible health plans and catastrophic plans to the extent permitted by federal law

The Attorney General must investigate epinephrine drug pricing practices and submit a public report to the General Assembly within one year, including policy recommendations to prevent overpricing

The Insurance Department may promulgate regulations to enforce the $35 price cap, and insurers are permitted to offer lower cost-sharing amounts than required

The act takes effect 60 days after enactment and applies to policies issued, renewed, or amended after that date